NO20024810L - Dermatologisk preparat samt anvendelse derav - Google Patents

Dermatologisk preparat samt anvendelse derav

Info

Publication number
NO20024810L
NO20024810L NO20024810A NO20024810A NO20024810L NO 20024810 L NO20024810 L NO 20024810L NO 20024810 A NO20024810 A NO 20024810A NO 20024810 A NO20024810 A NO 20024810A NO 20024810 L NO20024810 L NO 20024810L
Authority
NO
Norway
Prior art keywords
dermatological preparation
dermatological
preparation
Prior art date
Application number
NO20024810A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024810D0 (no
Inventor
Pekko Heino
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of NO20024810D0 publication Critical patent/NO20024810D0/no
Publication of NO20024810L publication Critical patent/NO20024810L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
NO20024810A 2000-04-06 2002-10-04 Dermatologisk preparat samt anvendelse derav NO20024810L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Publications (2)

Publication Number Publication Date
NO20024810D0 NO20024810D0 (no) 2002-10-04
NO20024810L true NO20024810L (no) 2002-12-06

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024810A NO20024810L (no) 2000-04-06 2002-10-04 Dermatologisk preparat samt anvendelse derav

Country Status (14)

Country Link
US (2) US20030144359A1 (enExample)
EP (1) EP1274416A1 (enExample)
JP (1) JP2003530349A (enExample)
AU (1) AU2001235506A1 (enExample)
CA (1) CA2405425A1 (enExample)
CH (1) CH695983A5 (enExample)
DE (1) DE10196025T1 (enExample)
DK (1) DK200201483A (enExample)
ES (1) ES2193003B1 (enExample)
FI (1) FI107018B (enExample)
GB (1) GB2377380B (enExample)
NO (1) NO20024810L (enExample)
SE (1) SE0202886L (enExample)
WO (1) WO2001076589A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
AU2004273986B2 (en) * 2003-09-15 2010-04-22 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use in angiogenesis
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
EP2120913B1 (en) 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2010075332A1 (en) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Small molecule ligands of the integrin rgd recognition site and methods of use
US9180107B2 (en) 2009-03-31 2015-11-10 Nanopharmaceuticals Llc Combination treatment of cancer with cetuximab and tetrac
WO2010148007A2 (en) 2009-06-17 2010-12-23 Ordway Research Institute, Inc. Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
AU2017279536A1 (en) 2016-06-07 2018-12-20 Nanopharmaceuticals, Llc Non-cleavable polymer conjugated with αvβ3 integrin thyroid antagonists
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
CA2184002A1 (en) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Method and compositions for increasing the serum half-life of pharmacologically active agents
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
AU780503B2 (en) * 1999-04-26 2005-03-24 Albert Burger Pharmaceutical compositions of tetrac and methods of use thereof
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
DE10196025T1 (de) 2003-03-13
EP1274416A1 (en) 2003-01-15
SE0202886D0 (sv) 2002-10-01
FI20000818A0 (fi) 2000-04-06
GB2377380B (en) 2004-07-14
US20030144359A1 (en) 2003-07-31
AU2001235506A1 (en) 2001-10-23
DK200201483A (da) 2002-10-03
ES2193003A1 (es) 2003-10-16
CA2405425A1 (en) 2001-10-18
GB0222880D0 (en) 2002-11-13
US20050272817A1 (en) 2005-12-08
CH695983A5 (de) 2006-11-15
SE0202886L (sv) 2002-12-02
WO2001076589A1 (en) 2001-10-18
GB2377380A (en) 2003-01-15
NO20024810D0 (no) 2002-10-04
ES2193003B1 (es) 2005-02-01
FI107018B (fi) 2001-05-31
JP2003530349A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
NO20023616L (no) Ny anvendelse
NO20034805D0 (no) CRIPTO-blokkerende antistoff samt anvendelse derav
IS6779A (is) Mannlíkt mótefni gegn LT-beta-R
ID26389A (id) Popok sekali pakai
DE60106275D1 (de) Dermatologisches mittel
ID30590A (id) Celana sekali pakai jenis-celana pendek
ATE342708T1 (de) Kosmetiktuch
DE60139763D1 (de) Lanzen und -tieren
NO20024806D0 (no) Apomorfinderivater samt anvendelse derav
NO20024810D0 (no) Dermatologisk preparat samt anvendelse derav
DE60128470D1 (de) Haarpflegezubereitung
DE60102651D1 (de) Spannungsmessgerät
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
DE50104294D1 (de) Kosmetische zubereitungen mit waltheria indica extrakten und ferulasäure
DE60102459D1 (de) Lockenwickler
NO20025081D0 (no) Stabilt flytende preparat
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
NO20023392L (no) Preparat
DE50114299D1 (de) Schraubvorrichtung
DE60137845D1 (de) Rauscharmes spektroskopisches ellipsometer
NO20023003L (no) Benzofenon-glykopyranosider, samt fremstilling og terapeutisk anvendelse
FR2804602B1 (fr) Preparations cosmetiques
TR200000053A3 (tr) Dermatolojik preparat.
NO20005909D0 (no) Soppbasert middel samt fremstilling og anvendelse av dette
ATA7922000A (de) Elektromedizinisches gerät

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application